Maternal obesity and pregnancy.
Hemant K Satpathy1, Alfred Fleming, Donald Frey
1Department of OB-GYN, Creighton University Medical Center, Omaha, NE 68105, USA.
Postgraduate Medicine
|October 1, 2008
Summary
Obesity in pregnancy poses significant risks, increasing complications for both mother and child. Preconception weight loss and careful monitoring during pregnancy are crucial for managing these risks and ensuring healthier outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Public Health
Background:
- Obesity is a global pandemic with increasing prevalence, particularly affecting females.
- High body mass index (BMI) during pregnancy signifies a high-risk state with numerous potential complications.
- Obese pregnant individuals face increased risks of infertility, miscarriage, congenital anomalies, and gestational complications.
Purpose of the Study:
- To review the complications associated with obesity during pregnancy.
- To outline strategies for managing high-risk pregnancies in obese patients.
- To emphasize the importance of preconception counseling and targeted screening.
Main Methods:
- Literature review of complications linked to maternal obesity.
- Discussion of screening protocols for common gestational complications.
- Overview of management strategies during pregnancy, labor, and postpartum.
Main Results:
- Obesity is linked to infertility, early miscarriage, neural tube defects, gestational diabetes, hypertension, thromboembolism, and macrosomia.
- Obese women have higher rates of Cesarean delivery and postpartum wound complications.
- Infants born to obese mothers are at increased risk of macrosomia, shoulder dystocia, and later-life obesity.
Conclusions:
- Preconception weight management is vital for reducing pregnancy risks.
- Close monitoring and screening for complications like gestational diabetes and hypertension are essential.
- Optimized delivery and postpartum care are necessary for obese pregnant patients and their infants.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...